PTEN and metabolic dysfunction-associated steatohepatitis: In 2015, Wang et al. developed a mouse model mimicking Nonalcoholic steatohepatitis (NASH) using AdV-delivered SpCas9 targeting Pten. The NASH phenotype resulted from the Pten mutation as well as humoral and cellular immunity against SpCas9 [36].